Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors
NCT04627740
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Retroviral vector-transduced autologous T cells to express anti-ALPP CARs
Sponsor
Xinqiao Hospital of Chongqing
Collaborators
[object Object]